Text to be removed highlighted in red.
1 Medical Services for State Prisoners. Amend RSA 623-C:2, III to read as follows:
III. Pharmacists shall substitute generically equivalent drug products for all legend and non-legend prescriptions paid for by the department of corrections, including the Medicaid program, unless the prescribing practitioner specifies that the brand name drug product is medically necessary. Such notification shall be in the practitioner's own handwriting and shall be retained in the pharmacist's file. The commissioner of the department of corrections may waive the application of RSA 623-C:2, I if the commissioner determines such action is necessary to ensure the availability of prescription and other pharmaceutical services to persons served by the state or to avert serious economic hardship in the provision of prescriptions and other pharmaceutical services. For Medicaid fee for service clients, no prior authorization for generically equivalent drugs shall be required.
2 Effective Date. This act shall take effect 60 days after its passage.
Text to be added highlighted in green.
1 Medical Services for State Prisoners. Amend RSA 623-C:2, III to read as follows:
III. Pharmacists shall substitute generically equivalent drug products for all legend and non-legend prescriptions paid for by the department of corrections, unless the prescribing practitioner specifies that the brand name drug product is medically necessary. The pharmacist shall not select an equivalent drug product unless its price to the purchaser or payor is less than the price of the prescribed drug product. The department may enter into agreements or collaborative purchasing structures to buy or acquire therapeutic agents that will result in cost savings to the department. The commissioner of the department of corrections may waive the application of RSA 623-C:2, I if the commissioner determines such action is necessary to ensure the availability of prescription and other pharmaceutical services to persons served by the state or to avert serious economic hardship in the provision of prescriptions and other pharmaceutical services.
2 Effective Date. This act shall take effect 60 days after its passage.